Tower Research Capital (TRC)’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8,280
| Closed | -$6K | – | 6524 |
|
|
2023
Q1 | $6K | Buy |
+8,280
| New | +$6K | ﹤0.01% | 4917 |
|
|
2022
Q4 | – | Sell |
-110
| Closed | -$1K | – | 6678 |
|
|
2022
Q3 | $1K | Buy |
+110
| New | +$1K | ﹤0.01% | 5934 |
|
|
2022
Q2 | – | Sell |
-1,782
| Closed | -$7K | – | 6822 |
|
|
2022
Q1 | $7K | Buy |
1,782
+1,590
| +828% | +$6.25K | ﹤0.01% | 4810 |
|
|
2021
Q4 | $1K | Sell |
192
-4,515
| -96% | -$23.5K | ﹤0.01% | 5975 |
|
|
2021
Q3 | $22K | Buy |
4,707
+2,206
| +88% | +$10.3K | ﹤0.01% | 3653 |
|
|
2021
Q2 | $18K | Sell |
2,501
-8,343
| -77% | -$60K | ﹤0.01% | 4018 |
|
|
2021
Q1 | $64K | Buy |
10,844
+2,391
| +28% | +$14.1K | ﹤0.01% | 2918 |
|
|
2020
Q4 | $39K | Sell |
8,453
-38,236
| -82% | -$176K | ﹤0.01% | 3356 |
|
|
2020
Q3 | $182K | Buy |
46,689
+45,276
| +3,204% | +$176K | ﹤0.01% | 2666 |
|
|
2020
Q2 | $41K | Buy |
+1,413
| New | +$41K | ﹤0.01% | 3218 |
|